Apse's Unattributed Round

Apse raised a round of funding on October 28, 2013.

Apse is a biotechnology company seeking to commercialize a portfolio of Novel Nanomaterials useful for the manufacture of recombinant RNA and proteins and for Nanotechnology applications.…

Articles about Apse's Unattributed Round: